U

University of New Mexico Hospital | Carrie Tingley Hospital - Department of Orthopaedics

Research site

(Unclaimed)

Location

1127 University North East Boulevard, Albuquerque, New Mexico, United States of America

Site insights

Top conditions

Top treatments

Aspirin

SR34006

YM872

Steroid

Fluid Chloride

Eptifibatide

Argatroban

Pramipexole

HCl

Clopidogrel

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 47 total trials

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

This is a nonrandomized study of ruxolitinib in combination with a standard multi-agent chemotherapy regimen for the treatment of B-cell acute lympho...

Active, not recruiting

Leukemia

Drug: Methotrexate

Drug: Thioguanine

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lo...

Enrolling

Stroke

Intracranial Arteriosclerosis

Other: Risk Factor Management

Drug: Rivaroxaban + Aspirin

Emergency Department-Initiated Buprenorphine Validation Network Trial

This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation...

Active, not recruiting

Opioid-use Disorder

Drug: Buprenorphine Sublingual Product

Drug: CAM2038

PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) (Pediatric_PK)

Phase 1 study, a single dose of ZTI-01 given to pediatric subjects (under 12 years of age) who require antibiotic therapy to see what the body does t...

Enrolling

Pediatric ALL

Drug: ZTI-01 75 mg/kg

Drug: ZTI-01 100 mg/kg

Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).

The main goal of this clinical trial is to check if the treatment is safe and well-tolerated. Researchers will compare the MR-301 active drug group w...

Enrolling

Traumatic Brain Injury

Drug: Placebo

Drug: Amantadine Hydrochloride